“Evaluating The Safety Profile Of Nintedanib Among ILD Patients In A Tertiary Care Hospital: A Prospective Research Approach Focusing On Adverse Drug Reactions”, Int. J. Environ. Sci., pp. 5496–5502, Oct. 2025, doi: 10.64252/69nwp181.